{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T13:51:07Z","timestamp":1781877067418,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Medical Research Project of Yancheng City Health and Wellness Committee","award":["YK2023066"],"award-info":[{"award-number":["YK2023066"]}]},{"DOI":"10.13039\/501100012154","name":"Graduate Research and Innovation Projects of Jiangsu Province","doi-asserted-by":"publisher","award":["Z2024062"],"award-info":[{"award-number":["Z2024062"]}],"id":[{"id":"10.13039\/501100012154","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-026-04250-7","type":"journal-article","created":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T05:51:46Z","timestamp":1769925106000},"page":"2832-2844","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sodium butyrate induces apoptosis enhanced by JAK2 inhibitor Fedratinib in NK\/T-cell lymphoma cell"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6416-2995","authenticated-orcid":false,"given":"Dongyun","family":"Tu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenya","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8489-5400","authenticated-orcid":false,"given":"Linyan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,1]]},"reference":[{"key":"4250_CR1","doi-asserted-by":"publisher","first-page":"103237","DOI":"10.1016\/j.critrevonc.2021.103237","volume":"159","author":"C Sanchez-Romero","year":"2021","unstructured":"Sanchez-Romero C, Bologna-Molina R, Paes de Almeida O, et al. Extranodal NK\/T cell lymphoma, nasal type: An updated overview. Crit Rev Oncol Hematol. 2021;159:103237.","journal-title":"Crit Rev Oncol Hematol."},{"issue":"1","key":"4250_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13045-019-0716-7","volume":"12","author":"S de Mel","year":"2019","unstructured":"de Mel S, Hue SS, Jeyasekharan AD, Chng WJ, Ng SB. Molecular pathogenic pathways in extranodal NK\/T cell lymphoma. J Hematol Oncol. 2019;12(1):33.","journal-title":"J Hematol Oncol"},{"issue":"4","key":"4250_CR3","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.coph.2006.03.010","volume":"6","author":"N Carey","year":"2006","unstructured":"Carey N, La Thangue NB. Histone deacetylase inhibitors: gathering pace. Curr Opin Pharmacol. 2006;6(4):369\u201375.","journal-title":"Curr Opin Pharmacol"},{"key":"4250_CR4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.biocel.2018.03.004","volume":"98","author":"M Conte","year":"2018","unstructured":"Conte M, De Palma R, Altucci L. HDAC inhibitors as epigenetic regulators for cancer immunotherapy. Int J Biochem Cell Biol. 2018;98:65\u201374.","journal-title":"Int J Biochem Cell Biol"},{"issue":"4","key":"4250_CR5","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/gutjnl-2024-333530","volume":"74","author":"Z Shi","year":"2025","unstructured":"Shi Z, Li M, Zhang C, et al. Butyrate-producing Faecalibacterium prausnitzii suppresses natural killer\/T-cell lymphoma by dampening the JAK-STAT pathway. Gut. 2025;74(4):557\u201370.","journal-title":"Gut"},{"key":"4250_CR6","doi-asserted-by":"publisher","first-page":"1068662","DOI":"10.3389\/fimmu.2023.1068662","volume":"14","author":"DR Yap","year":"2023","unstructured":"Yap DR, Lim JQ, Huang D, Ong CK, Chan JY. Emerging predictive biomarkers for novel therapeutics in peripheral T-cell and natural killer\/T-cell lymphoma. Front Immunol. 2023;14:1068662.","journal-title":"Front Immunol."},{"issue":"3","key":"4250_CR7","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.ccell.2020.02.005","volume":"37","author":"J Xiong","year":"2020","unstructured":"Xiong J, Cui B-W, Wang N, et al. Genomic and Transcriptomic Characterization of Natural Killer T Cell Lymphoma. Cancer Cell. 2020;37(3):403-19.e6.","journal-title":"Cancer Cell"},{"key":"4250_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104420","author":"T Wen","year":"2023","unstructured":"Wen T, Sun G, Jiang W, et al. Histone deacetylases inhibitor chidamide synergizes with humanized PD1 antibody to enhance T-cell chemokine expression and augment Ifn-\u03b3 response in NK-T cell lymphoma. EBioMedicine. 2023. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104420.","journal-title":"EBioMedicine"},{"issue":"3","key":"4250_CR9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.4161\/epi.1.3.3328","volume":"1","author":"TC Karagiannis","year":"2006","unstructured":"Karagiannis TC, El-Osta A. Clinical potential of histone deacetylase inhibitors as stand alone therapeutics and in combination with other chemotherapeutics or radiotherapy for cancer. Epigenetics. 2006;1(3):121\u20136.","journal-title":"Epigenetics"},{"issue":"15","key":"4250_CR10","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.2174\/0929867325666181016163110","volume":"27","author":"L Cappellacci","year":"2020","unstructured":"Cappellacci L, Perinelli DR, Maggi F, Grifantini M, Petrelli R. Recent progress in histone deacetylase inhibitors as anticancer agents. Curr Med Chem. 2020;27(15):2449\u201393.","journal-title":"Curr Med Chem"},{"issue":"1","key":"4250_CR11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1079\/PNS2002215","volume":"62","author":"HM Blottiere","year":"2003","unstructured":"Blottiere HM, Buecher B, Galmiche JP, Cherbut C. Molecular analysis of the effect of short-chain fatty acids on intestinal cell proliferation. Proc Nutr Soc. 2003;62(1):101\u20136.","journal-title":"Proc Nutr Soc"},{"issue":"17","key":"4250_CR12","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.2174\/0929867324666170801102124","volume":"26","author":"LM Zhao","year":"2019","unstructured":"Zhao LM, Zhang JH. Histone deacetylase inhibitors in tumor immunotherapy. Curr Med Chem. 2019;26(17):2990\u20133008.","journal-title":"Curr Med Chem"},{"key":"4250_CR13","first-page":"1038","volume":"19","author":"F Forouzesh","year":"2020","unstructured":"Forouzesh F, Ghiaghi M, Rahimi H. Effect of sodium butyrate on HDAC8 mRNA expression in colorectal cancer cell lines and molecular docking study of LHX1 - sodium butyrate interaction. EXCLI J. 2020;19:1038\u201351.","journal-title":"EXCLI J"},{"issue":"5","key":"4250_CR14","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1093\/jn\/132.5.1012","volume":"132","author":"BF Hinnebusch","year":"2002","unstructured":"Hinnebusch BF, Meng S, Wu JT, Archer SY, Hodin RA. The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation. J Nutr. 2002;132(5):1012\u20137.","journal-title":"J Nutr"},{"issue":"4","key":"4250_CR15","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.suronc.2018.07.015","volume":"27","author":"DI Tsilimigras","year":"2018","unstructured":"Tsilimigras DI, Ntanasis-Stathopoulos I, Moris D, Spartalis E, Pawlik TM. Histone deacetylase inhibitors in hepatocellular carcinoma: a therapeutic perspective. Surg Oncol. 2018;27(4):611\u20138.","journal-title":"Surg Oncol"},{"issue":"3","key":"4250_CR16","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2217\/epi-2018-0081","volume":"11","author":"DQ Calcagno","year":"2019","unstructured":"Calcagno DQ, Wisnieski F, Mota E, et al. Role of histone acetylation in gastric cancer: implications of dietetic compounds and clinical perspectives. Epigenomics. 2019;11(3):349\u201362.","journal-title":"Epigenomics"},{"key":"4250_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2021.153396","volume":"220","author":"G Rahmani","year":"2021","unstructured":"Rahmani G, Sameri S, Abbasi N, Abdi M, Najafi R. The clinical significance of histone deacetylase-8 in human breast cancer. Pathol Res Pract. 2021;220:153396.","journal-title":"Pathol Res Pract"},{"key":"4250_CR18","doi-asserted-by":"publisher","first-page":"862977","DOI":"10.3389\/fgene.2022.862977","volume":"13","author":"C Song","year":"2022","unstructured":"Song C, Lin W, Meng H, Li N, Geng Q. Integrated Analysis Reveals the Potential Significance of HDAC Family Genes in Lung Adenocarcinoma. Front Gene. 2022;13:862977.","journal-title":"Front Gene."},{"issue":"5","key":"4250_CR19","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3892\/ol.2020.12011","volume":"20","author":"B Shi","year":"2020","unstructured":"Shi B, Xu FF, Xiang CP, et al. Effect of sodium butyrate on ABC transporters in lung cancer A549 and colorectal cancer HCT116 cells. Oncol Lett. 2020;20(5):148.","journal-title":"Oncol Lett"},{"issue":"1","key":"4250_CR20","first-page":"210","volume":"45","author":"Y Du","year":"2020","unstructured":"Du Y, Tang G, Yuan W. Suppression of HDAC2 by sodium butyrate alleviates apoptosis of kidney cells in db\/db mice and HGinduced NRK52E cells. Int J Mol Med. 2020;45(1):210\u201322.","journal-title":"Int J Mol Med"},{"issue":"3","key":"4250_CR21","doi-asserted-by":"publisher","first-page":"795","DOI":"10.31557\/APJCP.2022.23.3.795","volume":"23","author":"M Sanaei","year":"2022","unstructured":"Sanaei M, Kavoosi F. Effect of sodium butyrate on p16INK4a, p14ARF, p15INK4b, class I HDACs (HDACs 1, 2, 3) class II HDACs (HDACs 4, 5, 6), cell growth inhibition and apoptosis induction in pancreatic cancer AsPC-1 and colon cancer HCT-116 cell lines. Asian Pac J Cancer Prev. 2022;23(3):795\u2013802.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1-2","key":"4250_CR22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11010-005-9054-x","volume":"285","author":"Y-F Wang","year":"2006","unstructured":"Wang Y-F, Chen N-S, Chung Y-P, et al. Sodium butyrate induces apoptosis and cell cycle arrest in primary effusion lymphoma cells independently of oxidative stress and p21CIP1\/WAF1 induction. Mol Cell Biochem. 2006;285(1\u20132):51\u20139.","journal-title":"Mol Cell Biochem"},{"issue":"11","key":"4250_CR23","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1080\/15548627.2015.1091911","volume":"11","author":"M Granato","year":"2015","unstructured":"Granato M, Santarelli R, Filardi M, et al. The activation of KSHV lytic cycle blocks autophagy in PEL cells. Autophagy. 2015;11(11):1978\u201386.","journal-title":"Autophagy"},{"issue":"7","key":"4250_CR24","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.2174\/18715206113139990130","volume":"13","author":"H Sun","year":"2013","unstructured":"Sun H, Wang Z, Yakisich JS. Natural products targeting autophagy via the PI3K\/Akt\/mTOR pathway as anticancer agents. Anticancer Agents Med Chem. 2013;13(7):1048\u201356.","journal-title":"Anticancer Agents Med Chem"},{"key":"4250_CR25","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/bs.ircmb.2020.01.003","volume":"352","author":"WD Fairlie","year":"2020","unstructured":"Fairlie WD, Tran S, Lee EF. Crosstalk between apoptosis and autophagy signaling pathways. Int Rev Cell Mol Biol. 2020;352:115\u201358.","journal-title":"Int Rev Cell Mol Biol"},{"key":"4250_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2017.05.033","author":"B Groner","year":"2017","unstructured":"Groner B, von Manstein V. Jak stat signaling and cancer: opportunities, benefits and side effects of targeted inhibition. Mol Cell Endocrinol. 2017. https:\/\/doi.org\/10.1016\/j.mce.2017.05.033.","journal-title":"Mol Cell Endocrinol"},{"key":"4250_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2024.1360878","author":"Q Lin","year":"2024","unstructured":"Lin Q, Zhou J, Yang F, et al. Sodium butyrate impedes the lymphoma caused by Marek\u2019s disease virus via regulating the mitochondrial apoptosis pathway. Front Vet Sci. 2024. https:\/\/doi.org\/10.3389\/fvets.2024.1360878.","journal-title":"Front Vet Sci"},{"key":"4250_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-005-9054-x","author":"Y-F Wang","year":"2006","unstructured":"Wang Y-F, Chen N-S, Chung Y-P, et al. Sodium butyrate induces apoptosis and cell cycle arrest in primary effusion lymphoma cells independently of oxidative stress and p21(CIP1\/WAF1) induction. Mol Cell Biochem. 2006. https:\/\/doi.org\/10.1007\/s11010-005-9054-x.","journal-title":"Mol Cell Biochem"},{"key":"4250_CR29","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V106.11.4817.4817","author":"U Heider","year":"2005","unstructured":"Heider U, Kaiser M, Zavrski I, et al. Histone deacetylase inhibitors induce growth inhibition, cell cycle arrest and apoptosis in mantle cell lymphoma and reduce VEGF production. Blood. 2005. https:\/\/doi.org\/10.1182\/blood.V106.11.4817.4817.","journal-title":"Blood"},{"issue":"3","key":"4250_CR30","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.exphem.2012.10.012","volume":"41","author":"SM Gao","year":"2013","unstructured":"Gao SM, Chen CQ, Wang LY, et al. Histone deacetylases inhibitor sodium butyrate inhibits JAK2\/STAT signaling through upregulation of SOCS1 and SOCS3 mediated by HDAC8 inhibition in myeloproliferative neoplasms. Exp Hematol. 2013;41(3):261\u201370.","journal-title":"Exp Hematol."},{"issue":"1","key":"4250_CR31","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/PAP.0b013e3181916029","volume":"16","author":"SB Ng","year":"2009","unstructured":"Ng SB, Khoury JD. Epstein-Barr virus in lymphoproliferative processes: an update for the diagnostic pathologist. Adv Anat Pathol. 2009;16(1):40\u201355.","journal-title":"Adv Anat Pathol"},{"issue":"20","key":"4250_CR32","first-page":"5781","volume":"60","author":"EM Westphal","year":"2000","unstructured":"Westphal EM, Blackstock W, Feng W, Israel B, Kenney SC. Activation of lytic Epstein-Barr virus (EBV) infection by radiation and sodium butyrate in vitro and in vivo: a potential method for treating EBV-positive malignancies. Cancer Res. 2000;60(20):5781\u20138.","journal-title":"Cancer Res"},{"issue":"10","key":"4250_CR33","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1002\/ijc.24945","volume":"126","author":"KF Hui","year":"2010","unstructured":"Hui KF, Chiang AK. Suberoylanilide hydroxamic acid induces viral lytic cycle in Epstein-Barr virus-positive epithelial malignancies and mediates enhanced cell death. Int J Cancer. 2010;126(10):2479\u201389.","journal-title":"Int J Cancer"},{"issue":"4","key":"4250_CR34","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1182\/blood-2011-06-362434","volume":"119","author":"SK Ghosh","year":"2012","unstructured":"Ghosh SK, Perrine SP, Williams RM, Faller DV. Histone deacetylase inhibitors are potent inducers of gene expression in latent EBV and sensitize lymphoma cells to nucleoside antiviral agents. Blood. 2012;119(4):1008\u201317.","journal-title":"Blood"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04250-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04250-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04250-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T12:58:01Z","timestamp":1781873881000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-026-04250-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,1]]},"references-count":34,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["4250"],"URL":"https:\/\/doi.org\/10.1007\/s12094-026-04250-7","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,1]]},"assertion":[{"value":"17 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}